A few weeks ago, I was poring over the latest evidence-based guidelines for treating hypertension with one of our medical students, hoping it would enlighten us regarding how to craft our recommendations for a patient with persistent hypertension whom I had known for 15 years. On the surface, the American College of Cardiology/American Heart Association guidelines for treating hypertension seemed straightforward. We should add a third agent (calcium channel blocker) to the 2 she had already been prescribed (thiazide diuretic and angiotensin-converting enzyme inhibitor). When we looked for evidence to assure us that this recommendation was the best one for a patient with comorbid obesity, asthma, generalized anxiety disorder, depression, and polycystic ovary disease, we found very little. Furthermore, we reviewed quality metric parameters for how primary care physicians are assessed in adequately lowering a patient’s cardiovascular disease risk and found no guidance in how to factor in her history of adverse childhood experiences, unstable housing, unemployment, and food insecurity in assessing how much the addition of a new antihypertensive medication might lower her risk for cardiac disease.1-3 I did not have a good answer when she asked me, “Dr DeVoe, given my history and tendency to experience side effects with every new medication we try, is this one going to be any different?” And where was the evidence-based guideline to answer her questions about whether spending money to buy this medication was more important than buying the healthy foods we had also recommended?
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
DeVoe JE. Bridging the Gap Between Where the Quality Metric Ends and Real Life Begins—A Trusting Relationship. JAMA Intern Med. 2020;180(2):177–178. doi:10.1001/jamainternmed.2019.5132
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: